首页> 外文期刊>Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease >Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation
【24h】

Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation

机译:总血栓形成分析系统(T-TAS)可以预测接受导管消融治疗房颤的患者围手术期出血事件

获取原文
       

摘要

Background Non–vitamin K antagonist oral anticoagulants are used to prevent thromboembolism in patients with atrial fibrillation. The T‐TAS “Total Thrombus‐formation Analysis System” (Fujimori Kogyo Co Ltd) was developed for quantitative analysis of thrombus formation using microchips with thrombogenic surfaces (collagen, platelet chip [PL] ; collagen plus tissue factor, atheroma chip [AR]). We evaluated the utility of T‐TAS in predicting periprocedural bleeding in atrial fibrillation patients undergoing catheter ablation (CA).
机译:背景技术非维生素K拮抗剂口服抗凝药可用于预防房颤患者的血栓栓塞。开发了T‐TAS“总血栓形成分析系统”(藤森工业公司),用于使用具有血栓形成表面的微芯片(胶原蛋白,血小板芯片[PL];胶原蛋白加上组织因子,动脉粥样硬化芯片[AR])定量分析血栓形成。 )。我们评估了T‐TAS在预测接受导管消融(CA)的房颤患者围手术期出血中的效用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号